A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
Targeting a molecule called B7-H4 may lead to the development of new therapies that boost the immune system’s ability to fight cancer, according to a review published in the journal Immunological Reviews.
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
Northwestern University synthetic biologists have developed a general method for “rewiring” immune cells to help overcome immunosuppression in cancer.
A Northwestern Medicine study, led by a fifth-year PhD student, has demonstrated that a cytokine known to be important in allergic disease called interleukin-33 (IL-33) plays a key role regulating stem cells under normal, healthy conditions.
Northwestern Medicine scientists continue to demonstrate that a protein called Hrd1 may be an important target for treating autoimmune diseases.
Northwestern Medicine scientists have identified a new potential target for treating autoimmune diseases in recent research published in Nature Communications.
Northwestern Medicine scientists discovered a crucial element underlying how proteins on the surface of enveloped viruses such as measles and mumps undergo a process that allows the virus to enter host cells.
Northwestern Medicine scientists take innovative cell-based approaches to induce immune tolerance In kidney transplant recipients.
A new drug safely and effectively treats patients with ulcerative colitis, according to a recent study co-authored by Northwestern Medicine investigator Stephen Hanauer, MD.